The role of SIRT1 expression–activity on progression and prognosis of gliomas can now be investigated more accurately using quantitative imaging of SIRT1 expression–activity in tumor tissue in vivo, in the native microenvironment of individual tumors. Here, SIRT1 is linked to central nervous system cancer.